Track 2 – Digital Biopharma
About Medison Ventures
Medison Ventures is the corporate venture arm of Medison, Israel’s second largest pharma company and the leading commercial partner for global companies such as Amgen®, Biogen®, Vertex®, Ipsen® and many more. Medison ventures is focused on in-licensing, investments and scouting of innovative therapeutics and digital health solutions, which hold the potential to make a real positive difference in patients’ lives and create value for Medison and its global biotech and pharma partners.
Areas of interest: patient/physician engagement, marketing, medication adherence, home treatment, digital therapeutics, digital diagnostics, clinical trial management;
Therapeutic Areas of Focus: cardiovascular, neurology, oncology, hematology, bone health/endocrinology, rare/orphan diseases; Preferably with a market ready and /or clinically validated;
Business Scenario: Pharma-oriented value proposition;
Award: The winning company will join Medison’s scouting program for one year. Companies will gain access to Medison’s broad network of pharma partners and will be introduced to relevant digital and commercial functions. In addition, Medison will provide the winning company periodic commercial strategy consultation by experts from Medison and its network.
Judging Criteria: Fit to Modality and/or therapeutic area of focus; Sound business model; Innovativeness; Team; Significance (unmet need); Commercial launch plan;
Eligibility: Fit to abovementioned modality and/or therapeutic area of focus; At least at POC stage;